BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21197682)

  • 1. Maternal screening and postpartum vaccination for measles infection in Japan: a cohort study.
    Shoda A; Hayashi M; Takayama N; Oshima K; Nishikawa M; Okazaki T; Negishi M; Hayashida S; Watanabe H; Inaba N
    BJOG; 2011 Jan; 118(1):88-92. PubMed ID: 21197682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles virus haemagglutination-inhibition antibodies among pregnant and non-pregnant women in the vaccine era in Harare, Zimbabwe.
    Obi CL; Tswana SA; Moyo SR; Berejena C
    Cent Afr J Med; 1996 May; 42(5):135-8. PubMed ID: 8771931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team.
    Markowitz LE; Albrecht P; Rhodes P; Demonteverde R; Swint E; Maes EF; Powell C; Patriarca PA
    Pediatrics; 1996 Jan; 97(1):53-8. PubMed ID: 8545224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds].
    Liu BY; Feng ZX; Xu AQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):263-5. PubMed ID: 8706090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study.
    Leuridan E; Hens N; Hutse V; Ieven M; Aerts M; Van Damme P
    BMJ; 2010 May; 340():c1626. PubMed ID: 20483946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 8. Measles active and passive immunity in a worldwide perspective.
    Black FL
    Prog Med Virol; 1989; 36():1-33. PubMed ID: 2685909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Loss of maternal measles antibodies acquired by vaccination against measles].
    Strauss J; Mrázová M; Macátová I; Beranová I
    Cesk Epidemiol Mikrobiol Imunol; 1991 May; 40(3):137-43. PubMed ID: 1828716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The study of countermeasures on measles control in infants].
    Wang L; Sun L; Jiang Z; Kang S; Liu Y; Jiang X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):49-50. PubMed ID: 11860845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.
    Hutchins SS; Redd SC; Schrag S; Kruszon-Moran D; Wooten K; McQuillan GM; Bellini W; Meyer PA; Hadler S
    MedGenMed; 2001 Jan; ():E5. PubMed ID: 11320344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran.
    Karimi A; Arjomandi A; Alborzi A; Rasouli M; Kadivar MR; Obood B; Pourabbas B
    East Mediterr Health J; 2004; 10(4-5):468-73. PubMed ID: 16335636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Age-related loss of maternal antibodies against measles in children in La Plata].
    del Buono MB; Vaschetti P; Iannicelli J; Silber R
    Rev Argent Microbiol; 2003; 35(2):102-5. PubMed ID: 12920993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waning immunity and subclinical measles infections in England.
    Glass K; Grenfell BT
    Vaccine; 2004 Sep; 22(29-30):4110-6. PubMed ID: 15364464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.